Clinical Trials Browser

Adenocarcinoma, Prostatic Neoplasms

NCT00492050 2026-03-11

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Phase 2 Active not recruiting

46 enrolled 10 charts

Lymphoid

Waldenstrom Macroglobulinemia

NCT06914479 2026-03-11

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Phase 1 Recruiting

11 enrolled

CNS

Brain Neoplasms

NCT07346144 2026-03-04

ADePT

Phase 1/2 Not yet recruiting

68 enrolled

CNS

Glioblastoma

NCT05536349 2026-02-24

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

Phase 2 Recruiting

60 enrolled

Other hematologic neoplasm

Leukemia

NCT07363031 2026-01-23

Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy

Phase 2 Enrolling by invitation

84 enrolled

Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT07294547 2025-12-19

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Phase NA Recruiting

80 enrolled

Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT02768363 2025-07-30

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

Phase 2 Active not recruiting

187 enrolled

Genitourinary

Prostatic Neoplasms

NCT03004183 2024-10-15

STOMP

Phase 2 Completed

57 enrolled 12 charts

BreastThoracic

Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT00589875 2024-04-03

BrTK02

Phase 2 Completed

52 enrolled 10 charts

CNS

Astrocytoma, Glioblastoma, Glioma

NCT02831933 2023-09-21

ENSIGN

Phase 2 Terminated

11 enrolled 9 charts

DermatologicThoracic

Uveal Melanoma, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT00638612 2023-08-25

PaTK01

Phase 1 Completed

27 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00751270 2023-08-25

BrTK01

Phase 1 Completed

15 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma

NCT01997190 2023-08-25

MpeTK01

Phase 1 Completed

19 enrolled

BreastGynecologicOther solid neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Mesothelioma, Ovarian Neoplasms, Pleural Effusion, Malignant

NCT01972035 2022-04-12

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

Phase 2 Completed

137 enrolled 8 charts

Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT03541928 2021-04-06

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Phase 2 Unknown

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT00042328 2015-08-24

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

Phase 2 Completed

30 enrolled

Tumor-Agnostic

Neoplasms

NCT00562770 2012-07-31

Oral Valganciclovir Versus Valacyclovir

Phase 2 Completed

46 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00274404 2011-10-27

Controlled Trial of Valacyclovir in Infectious Mononucleosis

Phase 1/2 Completed

20 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

Clinical Trials

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

ADePT

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

STOMP

BrTK02

ENSIGN

PaTK01

BrTK01

MpeTK01

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients

Oral Valganciclovir Versus Valacyclovir

Controlled Trial of Valacyclovir in Infectious Mononucleosis